TY - JOUR
KW - anticoagulation
KW - Atrial fibrillation
KW - Cancer
KW - oral anticoagulant
KW - prescribing
AU - A. Ajabnoor
AU - R. Parisi
AU - S. Zghebi
AU - D. Ashcroft
AU - C. Faivre-Finn
AU - C. Morris
AU - M. Mamas
AU - E. Kontopantelis
AD - Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
National Institute for Health and Care Research (NIHR), Greater Manchester Patient Safety Translational Research Centre (PSTRC), University of Manchester, Manchester, UK.
Christie National Health Service Foundation Trust and University of Manchester, Manchester, UK.
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK.
AN - 38115738
BT - Cancer
DO - 10.1002/cncr.35152
DP - NLM
ET - 2023/12/20
LA - eng
N1 - 1097-0142
Ajabnoor, Alyaa M
Orcid: 0000-0001-5154-6183
Parisi, Rosa
Zghebi, Salwa S
Ashcroft, Darren M
Faivre-Finn, Corinne
Morris, Charlotte
Mamas, Mamas A
Kontopantelis, Evangelos
Journal Article
United States
Cancer. 2023 Dec 20. doi: 10.1002/cncr.35152.
PY - 2023
SN - 0008-543x
T2 - Cancer
TI - Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019
ER -